Insight Molecular Diagnostics Inc. (IMDX)

Last Closing Price: 1.59 (2026-11-18)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Insight Molecular Diagnostics Inc. (IMDX) had Cost of Goods Sold of $0.14M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$0.56M
$-3.58M
Cost of Goods Sold
$0.14M
$0.42M
$4.24M
$-3.68M
$0.10M
$-3.58M
$-3.58M
$-3.58M
$-3.58M
$-3.58M
$-3.58M
$-3.68M
$-3.03M
36.86M
36.86M
$-0.10
$-0.10
Balance Sheet Financials
$13.88M
$5.55M
$7.86M
$21.74M
$9.51M
$0.50M
$36.41M
$45.92M
$-24.18M
$-24.18M
$-24.18M
32.76M
Cash Flow Statement Financials
$-23.34M
$-2.23M
$24.50M
$12.92M
$11.81M
$-1.10M
$2.10M
--
--
Fundamental Metrics & Ratios
1.46
--
--
-0.02
-0.02
75.13%
-657.60%
-657.60%
--
-640.25%
-640.25%
$-25.57M
--
--
--
0.03
0.37
1.07
83.72
14.80%
14.80%
-16.46%
15.11%
$-0.74
$-0.69
$-0.63